Skip to main content

Peer Review reports

From: Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4–5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial

Original Submission
10 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Reviewed Reviewer Report
27 Jul 2022 Author responded Author comments - Rafael Valdez-Ortiz
Resubmission - Version 4
27 Jul 2022 Submitted Manuscript version 4
29 Jul 2022 Author responded Author comments - Rafael Valdez-Ortiz
Resubmission - Version 5
29 Jul 2022 Submitted Manuscript version 5
9 Aug 2022 Reviewed Reviewer Report
22 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
25 Aug 2022 Editorially accepted
20 Sep 2022 Article published 10.1186/s12882-022-02930-4

You can find further information about peer review here.

Back to article page